Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 039935/0246 | |
| Pages: | 6 |
| | Recorded: | 10/04/2016 | | |
| Conveyance: | SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
6
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/19/2020
|
Application #:
|
15111065
|
Filing Dt:
|
07/12/2016
|
|
Publication #:
|
|
Pub Dt:
|
11/24/2016
| | | | |
|
Title:
|
COMBINATION-BASED TREATMENT METHOD
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
07/03/2018
|
Application #:
|
15120214
|
Filing Dt:
|
10/04/2016
|
|
Publication #:
|
|
Pub Dt:
|
05/11/2017
| | | | |
|
Title:
|
IL-2RBETA-SELECTIVE AGONISTS IN COMBINATION WITH AN ANTI-CTLA-4 ANTIBODY OR AN ANTI-PD-1 ANTIBODY
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
15216082
|
Filing Dt:
|
07/21/2016
|
|
Publication #:
|
|
Pub Dt:
|
12/29/2016
| | | | |
|
Title:
|
Methods, devices and Formulations For Targeted Endobronchial Therapy
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
10/09/2018
|
Application #:
|
15228793
|
Filing Dt:
|
08/04/2016
|
|
Publication #:
|
|
Pub Dt:
|
02/02/2017
| | | | |
|
Title:
|
PROTEASE INHIBITORS HAVING ENHANCED FEATURES
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
06/04/2019
|
Application #:
|
15247472
|
Filing Dt:
|
08/25/2016
|
|
Publication #:
|
|
Pub Dt:
|
12/29/2016
| | | | |
|
Title:
|
OLIGOMER-OPIOID AGONIST CONJUGATES
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/27/2018
|
Application #:
|
15254830
|
Filing Dt:
|
09/01/2016
|
|
Publication #:
|
|
Pub Dt:
|
03/23/2017
| | | | |
|
Title:
|
Compositions, Dosage Forms, and Co-Administration of an Opioid Agonist Compound and an Analgesic Compound
|
|
|
Assignee
|
|
|
|
|
| 301 COMMERCE STREET |
| SUITE 3300 |
| FORT WORTH, TEXAS 76102 |
|
|
Correspondence name and address
|
| |
NEKTAR THERAPEUTICS
|
| |
455 MISSION BAY BOULEVARD SOUTH
|
| |
SUITE 100
|
| |
SAN FRANCISCO, CA 94158
|
Search Results as of:
05/26/2024 09:22 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
